Citation:Gittelman MC, Hertzman B, Bailen J, Williams T, Koziol I, Henderson RJ, et al 2013

Citation

Gittelman MC, Hertzman B, Bailen J, Williams T, Koziol I, Henderson RJ, et al. PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study. J Urol 2013 Jul;190(1):64-9 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23416644.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Gittelman MC, Hertzman B, Bailen J, Williams T, Koziol I, Henderson RJ, et al 2013	In men who have been referred with suspected prostate cancer, what are the prognostic factors that determine the need for further investigation following a prior negative biopsy?	Katherine Sheridan	completed
Gittelman MC, Hertzman B, Bailen J, Williams T, Koziol I, Henderson RJ, et al 2013 2	In men who have been referred with suspected prostate cancer, what are the prognostic factors that determine the need for further investigation following a prior negative biopsy?	Dr Albert Chetcuti BTech(Biotech) Hons, PhD	completed

Compare quality appraisals for each clinical question

• [[Clinical question:In men who have been referred with suspected prostate cancer, what are the prognostic factors that determine the need for further investigation following a prior negative biopsy?|]] (compare critical appraisals)
• [[Clinical question:In men who have been referred with suspected prostate cancer, what are the prognostic factors that determine the need for further investigation following a prior negative biopsy?|]] (compare critical appraisals)

Cited by

1. Follow-up to a negative prostate biopsy